While SSRIs and SNRIs are effective for many, they have limitations. Side effects, delayed onset of action, partial responses, or treatment resistance all drive the search for alternatives. The review highlights that a broader neurobiological understanding of anxiety is now informing medication development beyond serotonin and norepinephrine.

Artificial intelligence is no longer a far-off concept in mental health care—it’s happening right now. At a recent American Psychiatric Association Innovation Lab, an AI-powered program aimed at identifying biological markers of mental illness received major recognition, signaling that technology is playing an increasingly serious role in how we diagnose and treat psychiatric conditions.

While psychiatric medications can be life-changing, they sometimes bring side effects that can interfere with daily life

ADHD is well-known for symptoms like distractibility and impulsivity, but there’s another set of cognitive difficulties that some people exp

The findings suggest that adding (or “augmenting”) another medication can be a valuable option

Sertraline and paroxetine have the stamp of approval for PTSD and have demonstrated small but consistent benefits across many trials

Our treatments, however, aims to reduce anxiety quickly without those extra downsides

One of the biggest benefits of nonstimulants is their lower risk profile.